{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,21]],"date-time":"2026-05-21T01:28:17Z","timestamp":1779326897636,"version":"3.51.4"},"reference-count":65,"publisher":"BMJ","issue":"2","license":[{"start":{"date-parts":[[2024,2,28]],"date-time":"2024-02-28T00:00:00Z","timestamp":1709078400000},"content-version":"unspecified","delay-in-days":27,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100024396","name":"Healthcare Quality Improvement Partnership","doi-asserted-by":"publisher","award":["Not applicable"],"award-info":[{"award-number":["Not applicable"]}],"id":[{"id":"10.13039\/501100024396","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["BMJ Open"],"accepted":{"date-parts":[[2024,1,30]]},"published-print":{"date-parts":[[2024,2]]},"abstract":"<jats:sec>\n                  <jats:title>Objectives<\/jats:title>\n                  <jats:p>A national survey aimed to measure how men with prostate cancer perceived their involvement in and decisions around their care immediately after diagnosis. This study aimed to describe any differences found by socio-demographic groups.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Design<\/jats:title>\n                  <jats:p>Cross-sectional study of men who were diagnosed with and treated for prostate cancer.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Setting<\/jats:title>\n                  <jats:p>The National Prostate Cancer Audit patient-reported experience measures (PREMs) survey in England.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Participants<\/jats:title>\n                  <jats:p>Men diagnosed in 2014\u20132016, with non-metastatic prostate cancer, were surveyed. Responses from 32 796 men were individually linked to records from a national clinical audit and to administrative hospital data. Age, ethnicity, deprivation and disease risk classification were used to explore variation in responses to selected questions.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Primary and secondary outcome measures<\/jats:title>\n                  <jats:p>Responses to five questions from the PREMs survey: the proportion responding to the highest positive category was compared across the socio-demographic characteristics above.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Results<\/jats:title>\n                  <jats:p>When adjusted for other factors, older men were less likely than men under the age of 60 to feel side effects had been explained in a way they could understand (men 80+: relative risk (RR)=0.92, 95% CI 0.84 to 1.00), that their views were considered (RR=0.79, 95% CI 0.73 to 0.87) or that they were involved in decisions (RR=0.92, 95% CI 0.85 to 1.00). The latter was also apparent for men who were not white (black men: RR=0.89, 95% CI 0.82 to 0.98; Asian men: RR=0.85, 95% CI 0.75 to 0.96) and, to a lesser extent, for more deprived men.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Conclusions<\/jats:title>\n                  <jats:p>The observed discrepancies highlight the need for more focus on initiatives to improve the experience of ethnic minority patients and those older than 60 years. The findings also argue for further validation of discriminatory instruments to help cancer care providers fully understand the variation in the experience of their patients.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1136\/bmjopen-2023-078284","type":"journal-article","created":{"date-parts":[[2024,2,28]],"date-time":"2024-02-28T22:01:23Z","timestamp":1709157683000},"page":"e078284","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":9,"title":["What can patient-reported experience measures tell us about the variation in patients\u2019 experience of prostate cancer care? A cross-sectional study using survey data from the National Prostate Cancer Audit in England"],"prefix":"10.1136","volume":"14","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3819-8107","authenticated-orcid":false,"given":"Melanie","family":"Morris","sequence":"first","affiliation":[{"name":"Clinical Effectiveness Unit, Royal College of Surgeons of England, London, London, UK"},{"name":"Health Services Research & Policy, London School of Hygiene and Tropical Medicine, Faculty of Public Health and Policy, London, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Adrian","family":"Cook","sequence":"additional","affiliation":[{"name":"Clinical Effectiveness Unit, Royal College of Surgeons of England, London, London, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7470-3014","authenticated-orcid":false,"given":"Joanna","family":"Dodkins","sequence":"additional","affiliation":[{"name":"Clinical Effectiveness Unit, Royal College of Surgeons of England, London, London, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Derek","family":"Price","sequence":"additional","affiliation":[{"name":"Department of Surgery and Cancer, Imperial College London, London, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Steve","family":"Waller","sequence":"additional","affiliation":[{"name":"Clinical Effectiveness Unit, Royal College of Surgeons of England, London, London, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Syreen","family":"Hassan","sequence":"additional","affiliation":[{"name":"Health Services Research & Policy, London School of Hygiene and Tropical Medicine, Faculty of Public Health and Policy, London, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Arjun","family":"Nathan","sequence":"additional","affiliation":[{"name":"Clinical Effectiveness Unit, Royal College of Surgeons of England, London, London, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ajay","family":"Aggarwal","sequence":"additional","affiliation":[{"name":"Health Services Research & Policy, London School of Hygiene and Tropical Medicine, Faculty of Public Health and Policy, London, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Heather Ann","family":"Payne","sequence":"additional","affiliation":[{"name":"Consultant Clinical Oncologist, University College London Hospitals NHS Foundation Trust, London, London, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Noel","family":"Clarke","sequence":"additional","affiliation":[{"name":"Clinical Effectiveness Unit, Royal College of Surgeons of England, London, London, UK"},{"name":"The Christie NHS Foundation Trust, Manchester, Manchester, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9451-2335","authenticated-orcid":false,"given":"Jan","family":"van der Meulen","sequence":"additional","affiliation":[{"name":"Health Services Research & Policy, London School of Hygiene and Tropical Medicine, Faculty of Public Health and Policy, London, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Julie","family":"Nossiter","sequence":"additional","affiliation":[{"name":"Clinical Effectiveness Unit, Royal College of Surgeons of England, London, London, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"239","published-online":{"date-parts":[[2024,2,28]]},"reference":[{"key":"2025101813442440000_14.2.e078284.1","unstructured":"Department of Health . High quality care for all. NHS next stage review. London: DoH, 2008."},{"key":"2025101813442440000_14.2.e078284.2","unstructured":"Independent Cancer Taskforce . Achieving world-class cancer outcomes: a strategy for England 2015-2020. London: NHS England, 2015."},{"key":"2025101813442440000_14.2.e078284.3","doi-asserted-by":"publisher","DOI":"10.1136\/bmjqs-2013-002707"},{"key":"2025101813442440000_14.2.e078284.4","doi-asserted-by":"crossref","first-page":"886","DOI":"10.1002\/pon.5362","article-title":"Decision regret in men living with and beyond Nonmetastatic prostate cancer in the United kingdom: A population-based patient-reported outcome study","volume":"29","author":"Wilding","year":"2020","journal-title":"Psychooncology"},{"key":"2025101813442440000_14.2.e078284.5","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2013-004567","article-title":"Inequalities in the care experiences of patients with cancer: analysis of data from the National cancer patient experience survey 2011-2012","volume":"4","author":"Bone","year":"2014","journal-title":"BMJ Open"},{"key":"2025101813442440000_14.2.e078284.6","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.euo.2018.02.003","article-title":"Satisfaction with care among men with Localised prostate cancer: A nationwide population-based study","volume":"1","author":"Bergengren","year":"2018","journal-title":"Eur Urol Oncol"},{"key":"2025101813442440000_14.2.e078284.7","doi-asserted-by":"crossref","first-page":"758","DOI":"10.1177\/2374373519889435","article-title":"Patient experience drivers of overall satisfaction with care in cancer patients: evidence from responders to the English cancer patient experience survey","volume":"7","author":"Gomez-Cano","year":"2020","journal-title":"J Patient Exp"},{"key":"2025101813442440000_14.2.e078284.8","unstructured":"NHS England . Achieving World-Class Cancer Outcomes: Taking the strategy forward. London: NHS England, 2016."},{"key":"2025101813442440000_14.2.e078284.9","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1016\/j.pec.2018.12.004","article-title":"Very difficult for an ordinary guy': factors influencing the quality of treatment decision-making amongst men diagnosed with Localised and locally advanced prostate cancer: findings from a UK-wide mixed methods study","volume":"102","author":"Wagland","year":"2019","journal-title":"Patient Educ Couns"},{"key":"2025101813442440000_14.2.e078284.10","unstructured":"NHS England . NHS improvement. National cancer patient experience survey. 2010. Available: https:\/\/www.ncpes.co.uk\/"},{"key":"2025101813442440000_14.2.e078284.11","doi-asserted-by":"crossref","first-page":"744","DOI":"10.1200\/JCO.19.01538","article-title":"Patient-reported functional outcomes after Hypofractionated or conventionally fractionated radiation for prostate cancer: A national cohort study in England","volume":"38","author":"Nossiter","year":"2020","journal-title":"J Clin Oncol"},{"key":"2025101813442440000_14.2.e078284.12","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1038\/bjc.2017.454","article-title":"Robot-assisted radical Prostatectomy vs Laparoscopic and open Retropubic radical Prostatectomy: functional outcomes 18 months after diagnosis from a national cohort study in England","volume":"118","author":"Nossiter","year":"2018","journal-title":"Br J Cancer"},{"key":"2025101813442440000_14.2.e078284.13","unstructured":"National Prostate Cancer Audit . Annual report 2017: results of the NPCA prospective audit in England and Wales for men diagnosed from 1 April 2015 - 31 March 2016. Contract No. 18 Jan. London The Royal College of Surgeons of England; 2018."},{"key":"2025101813442440000_14.2.e078284.14","unstructured":"National Prostate Cancer Audit . Annual report 2019: results of the NPCA prospective audit in England and Wales for men diagnosed from 1 April 2017 - 31 March 2018 (published January 2020). London The Royal College of Surgeons of England; 2020."},{"key":"2025101813442440000_14.2.e078284.15","doi-asserted-by":"crossref","first-page":"100344","DOI":"10.1016\/j.jcpo.2022.100344","article-title":"Practicalities, challenges and solutions to delivering a national Organisational survey of cancer service and processes: lessons from the National prostate cancer audit","volume":"33","author":"Dodkins","year":"2022","journal-title":"J Cancer Policy"},{"key":"2025101813442440000_14.2.e078284.16","doi-asserted-by":"crossref","DOI":"10.1016\/S0302-2838(21)01571-2","article-title":"Determinants of variation in radical local treatment for men with high-risk Localised or locally advanced prostate cancer in England","volume":"79","author":"Parry","year":"2021","journal-title":"European Urology"},{"key":"2025101813442440000_14.2.e078284.17","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1038\/s41391-021-00443-z","article-title":"Hospital volume and outcomes after radical Prostatectomy: a national population-based study using patient-reported urinary continence and sexual function","volume":"26","author":"Nossiter","year":"2023","journal-title":"Prostate Cancer Prostatic Dis"},{"key":"2025101813442440000_14.2.e078284.18","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1111\/bju.15663","article-title":"Urinary Incontinence and use of Incontinence surgery after radical Prostatectomy: a national study using patient-reported outcomes","volume":"130","author":"Parry","year":"2022","journal-title":"BJU Int"},{"key":"2025101813442440000_14.2.e078284.19","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1016\/j.adro.2017.12.008","article-title":"Factors influencing prostate cancer patterns of care: an analysis of treatment variation using the SEER database","volume":"3","author":"Burt","year":"2018","journal-title":"Adv Radiat Oncol"},{"key":"2025101813442440000_14.2.e078284.20","unstructured":"NHS Digital . 2018. Available: http:\/\/content.digital.nhs.uk\/hes [Accessed Jun 2020]."},{"key":"2025101813442440000_14.2.e078284.21","unstructured":"Office for National Statistics . List of ethnic groups - 2011 Census, Available: https:\/\/www.ethnicity-facts-figures.service.gov.uk\/style-guide\/ethnic-groups#2011-census"},{"key":"2025101813442440000_14.2.e078284.22","doi-asserted-by":"publisher","DOI":"10.1002\/bjs.6930"},{"key":"2025101813442440000_14.2.e078284.23","unstructured":"Noble M , McLennan D , Wilkinson K , et al . The English indices of deprivation 2007. 2007. Available: http:\/\/geoconvert.mimas.ac.uk\/help\/imd-2007-manual.pdf [Accessed 30 Sep 2020]."},{"key":"2025101813442440000_14.2.e078284.24","unstructured":"Ministry of Housing Communities & Local Government . English indices of deprivation: UK government. Available: https:\/\/www.gov.uk\/government\/collections\/english-indices-of-deprivation [Accessed May 2022]."},{"key":"2025101813442440000_14.2.e078284.25","unstructured":"National Prostate Cancer Audit . Third year annual report - results of the NPCA prospective audit and patient survey. 2016 Contract No.: February 16; 2016."},{"key":"2025101813442440000_14.2.e078284.26","doi-asserted-by":"publisher","DOI":"10.1016\/0749-2081(91)90085-4"},{"key":"2025101813442440000_14.2.e078284.27","doi-asserted-by":"publisher","DOI":"10.1111\/ecc.12267"},{"key":"2025101813442440000_14.2.e078284.28","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1016\/S1470-2045(18)30646-6","article-title":"Surgical treatment and survival from colorectal cancer in Denmark, England, Norway, and Sweden: a population-based study","volume":"20","author":"Benitez Majano","year":"2019","journal-title":"Lancet Oncol"},{"key":"2025101813442440000_14.2.e078284.29","unstructured":"National Cancer Intelligence Network . Major surgical resections\u2014England, 2004\u20132006. London: National Cancer Intelligence Network, 2011."},{"key":"2025101813442440000_14.2.e078284.30","unstructured":"National Cancer Equality Initiative, Pharmaceutical Oncology Initiative . The impact of patient age on clinical decision-making in oncology. London: Department of Health, 2012."},{"key":"2025101813442440000_14.2.e078284.31","unstructured":"National Institute for Health and Care Excellence . Prostate cancer: diagnosis and management (NG131). NICE, 2019."},{"key":"2025101813442440000_14.2.e078284.32","doi-asserted-by":"publisher","DOI":"10.1016\/j.eururo.2016.12.025"},{"key":"2025101813442440000_14.2.e078284.33","unstructured":"National Prostate Cancer Audit . Organisational Audit. London: The Royal College of Surgeons of England, 2021."},{"key":"2025101813442440000_14.2.e078284.34","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1038\/bjc.2017.452","article-title":"Which patients are not included in the English cancer waiting times monitoring Dataset, 2009-2013? implications for use of the data in research","volume":"118","author":"Di Girolamo","year":"2018","journal-title":"Br J Cancer"},{"key":"2025101813442440000_14.2.e078284.35","doi-asserted-by":"crossref","DOI":"10.1136\/bmj.g1614","article-title":"Ageism in cancer care","volume":"348","author":"Lawler","year":"2014","journal-title":"BMJ"},{"key":"2025101813442440000_14.2.e078284.36","doi-asserted-by":"publisher","DOI":"10.1038\/bjc.2014.472"},{"key":"2025101813442440000_14.2.e078284.37","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2009.27.3268"},{"key":"2025101813442440000_14.2.e078284.38","unstructured":"Williamson P , NHS Insights Feedback Team . NHS; Reducing inequalities in BME patient experience of cancer care, . 2020 Available: https:\/\/www.england.nhs.uk\/blog\/reducing-inequalities-bme-cancer-care\/ [Accessed Apr 2022]."},{"key":"2025101813442440000_14.2.e078284.39","doi-asserted-by":"crossref","DOI":"10.1186\/s12916-015-0405-5","article-title":"Lifetime risk of being diagnosed with, or dying from, prostate cancer by major ethnic group in England 2008\u20132010","volume":"13","author":"Lloyd","year":"2015","journal-title":"BMC Med"},{"key":"2025101813442440000_14.2.e078284.40","doi-asserted-by":"crossref","first-page":"1765","DOI":"10.1038\/s41416-022-01718-5","article-title":"Differences in cancer incidence by broad ethnic group in England, 2013\u20132017","volume":"126","author":"Delon","year":"2022","journal-title":"Br J Cancer"},{"key":"2025101813442440000_14.2.e078284.41","doi-asserted-by":"crossref","first-page":"1147","DOI":"10.1002\/pon.4222","article-title":"Ethnicity and the prostate cancer experience: a qualitative Metasynthesis","volume":"25","author":"Rivas","year":"2016","journal-title":"Psychooncology"},{"key":"2025101813442440000_14.2.e078284.42","article-title":"Adjustment strategies amongst black African and black Caribbean men following treatment for prostate cancer: findings from the life after prostate cancer diagnosis (LAPCD) study","volume":"29","author":"Wagland","year":"2020","journal-title":"Eur J Cancer Care (Engl)"},{"key":"2025101813442440000_14.2.e078284.43","unstructured":"B'Me against cancer hear me now!; 2020."},{"key":"2025101813442440000_14.2.e078284.44","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/j.radonc.2020.10.019","article-title":"Patient-reported functional outcomes following external beam radiation therapy for prostate cancer with and without a high-dose rate Brachytherapy boost: A national population-based study","volume":"155","author":"Parry","year":"2021","journal-title":"Radiother Oncol"},{"key":"2025101813442440000_14.2.e078284.45","doi-asserted-by":"publisher","DOI":"10.1111\/j.1369-7625.2005.00320.x"},{"key":"2025101813442440000_14.2.e078284.46","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1089\/jpm.2018.0591","article-title":"Is information provision about benefits and risks of treatment options associated with receiving person-centered care?: A survey among incurably ill cancer patients","volume":"22","author":"van Vliet","year":"2019","journal-title":"J Palliat Med"},{"key":"2025101813442440000_14.2.e078284.47","doi-asserted-by":"crossref","first-page":"1635","DOI":"10.1177\/1557988318780851","article-title":"Understanding medical decision-making in prostate cancer care","volume":"12","author":"Thera","year":"2018","journal-title":"Am J Mens Health"},{"key":"2025101813442440000_14.2.e078284.48","unstructured":"Wellings D , Lyratzopoulos G . Redesigning the cancer patient experience survey. 2016. Available: https:\/\/www.england.nhs.uk\/blog\/dan-wellings-2\/ [Accessed Mar 2021]."},{"key":"2025101813442440000_14.2.e078284.49","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2019-034344","article-title":"How representative are colorectal, lung, breast and prostate cancer patients responding to the National cancer patient experience survey (CPES) of the cancer Registry population in England? A population-based case control study","volume":"9","author":"Alessy","year":"2019","journal-title":"BMJ Open"},{"key":"2025101813442440000_14.2.e078284.50","first-page":"1024","article-title":"There\u2019s not enough bodies to do the demand:\" an exploration of key Stakeholder views on the role of health service capacity in shaping cancer outcomes in 7 International cancer Benchmarking partnership countries","volume":"11","author":"Seguin","year":"2022","journal-title":"Int J Health Policy Manag"},{"key":"2025101813442440000_14.2.e078284.51","unstructured":"Beech J , Bottery S , Charlesworth A , et al . Closing the Gap London: The Health Foundation. The King\u2019s Fund, Nuffield Trust, 2019."},{"key":"2025101813442440000_14.2.e078284.52","unstructured":"Health and Social Care Committee . Cancer Services. London: UK Parliament, 2022."},{"key":"2025101813442440000_14.2.e078284.53","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.12968\/bjon.2018.27.Sup4b.S1","article-title":"Continuous, comprehensive and crucial care: the role of the CNS in the metastatic Castration-resistant prostate cancer patient pathway","volume":"27","author":"Basketter","year":"2018","journal-title":"Br J Nurs"},{"key":"2025101813442440000_14.2.e078284.54","doi-asserted-by":"crossref","first-page":"2669","DOI":"10.1002\/cncr.34095","article-title":"Solidifying roles, responsibilities, and the process of navigation across the continuum of cancer care: the professional oncology navigation task force","volume":"128 Suppl 13","author":"Franklin","year":"2022","journal-title":"Cancer"},{"key":"2025101813442440000_14.2.e078284.55","doi-asserted-by":"crossref","DOI":"10.1136\/bmj.j1744","article-title":"Implementing shared decision making in the NHS: lessons from the MAGIC programme","volume":"357","author":"Joseph-Williams","year":"2017","journal-title":"BMJ"},{"key":"2025101813442440000_14.2.e078284.56","doi-asserted-by":"publisher","DOI":"10.1016\/j.pec.2009.09.010"},{"key":"2025101813442440000_14.2.e078284.57","doi-asserted-by":"publisher","DOI":"10.1002\/cncr.29064"},{"key":"2025101813442440000_14.2.e078284.58","doi-asserted-by":"crossref","first-page":"2035","DOI":"10.1016\/j.pec.2017.05.014","article-title":"The TRIO framework: conceptual insights into family Caregiver involvement and influence throughout cancer treatment decision-making","volume":"100","author":"Laidsaar-Powell","year":"2017","journal-title":"Patient Educ Couns"},{"key":"2025101813442440000_14.2.e078284.59","doi-asserted-by":"publisher","DOI":"10.1016\/j.clon.2018.03.009"},{"key":"2025101813442440000_14.2.e078284.60","doi-asserted-by":"crossref","first-page":"100233","DOI":"10.1016\/j.jcpo.2020.100233","article-title":"Understanding the link between health systems and cancer survival: A novel methodological approach using a system-level conceptual model","volume":"25","author":"Morris","year":"2020","journal-title":"Journal of Cancer Policy"},{"key":"2025101813442440000_14.2.e078284.61","first-page":"1756","article-title":"Exploring the role of leadership in facilitating change to improve cancer survival: an analysis of experiences in seven high income countries in the International cancer Benchmarking partnership (ICBP)","volume":"11","author":"Morris","year":"2022","journal-title":"Int J Health Policy Manag"},{"key":"2025101813442440000_14.2.e078284.62","unstructured":"World Health Organization (WHO) . National Cancer Control Programmes: Policies and Managerial Guidelines 2nd ed. Geneva: WHO, 2002."},{"key":"2025101813442440000_14.2.e078284.63","unstructured":"NHS England . National cancer patient experience survey - 2021 questionnaire. 2021."},{"key":"2025101813442440000_14.2.e078284.64","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2016-013555","article-title":"Life after prostate cancer diagnosis: protocol for a UK-wide patient-reported outcomes study","volume":"6","author":"Downing","year":"2016","journal-title":"BMJ Open"},{"key":"2025101813442440000_14.2.e078284.65","article-title":"A qualitative Metasynthesis exploring the impact of prostate cancer and its management on younger, Unpartnered and gay men","volume":"26","author":"Matheson","year":"2017","journal-title":"Eur J Cancer Care"}],"container-title":["BMJ Open"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/bmjopen-2023-078284","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,18]],"date-time":"2025-10-18T20:44:42Z","timestamp":1760820282000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmjopen.bmj.com\/lookup\/doi\/10.1136\/bmjopen-2023-078284"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,2]]},"references-count":65,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2024,2,28]]},"published-print":{"date-parts":[[2024,2]]}},"alternative-id":["10.1136\/bmjopen-2023-078284"],"URL":"https:\/\/doi.org\/10.1136\/bmjopen-2023-078284","relation":{},"ISSN":["2044-6055","2044-6055"],"issn-type":[{"value":"2044-6055","type":"print"},{"value":"2044-6055","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,2]]}}}